Glycosaminoglycans and arterial disease.
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000378:metabolism*; D001158:Arteries / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D001777:Blood Coagulation / Q000187:drug effects; D002395:Catecholamines / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002784:Cholesterol / Q000494:pharmacology; D004355:Drug Stability; D004789:Enzyme Activation / Q000187:drug effects; D005340:Fibrinogen / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism* / Q000502:physiology / Q000528:radiation effects; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D008407:Mast Cells / Q000378:metabolism; D011485:Protein Binding; D011830:Radiation Effects; D013329:Structure-Activity Relationship; D014945:Wound Healing
D002395:Catecholamines; D006025:Glycosaminoglycans; D006728:Hormones; D005340:Fibrinogen; D002784:Cholesterol